ROTHES PHARMA LIMITEDActive

Company number SC538432Private limited companyIncorporated 2016

Key figures

£79,190-44.0%
Net assets 2024/25
-22.3%
Average annual change 2019/20–2024/25
0100 k200 k300 k400 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, ROTHES PHARMA LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0250 k500 k750 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand138,440175,886193,476162,912146,087
Total assets597,971459,523545,516524,523449,547
Total liabilities————354,396
Net assets / total equity320,668185,220220,416141,45179,190
Average number of employees8109100

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ROTHES PHARMA LIMITED

Company

ROTHES PHARMA LIMITED is a private limited company registered with Companies House under company number SC538432. It was incorporated on 21 Jun 2016. Its status is active. The registered office is in Aberlour (AB38). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files small company accounts (filleted). Net assets were £79,190, down 44% on the previous year. Cash at bank and in hand was £146,087. Total assets were £449,547 and total liabilities £354,396. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 2 of 2 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 4 Jul 2027.